Beside the well-known cannabinoids THC and CBD up to 150 other cannabinoids are documented. Mostly, the pharmacological activities and biosynthesis is not studied and is difficult and very costly to isolate them from plant material. We develop innovative concepts to produce minor cannabinoids in relevant scales to cover the demand of the market based on biotechnology and phytochemistry.